Ibex Medical Analytics and PathPresenter have joined forces in a partnership to propel the adoption of AI-powered digital pathology. Ibex, a leader in AI-driven cancer diagnostics, will integrate its Galen™ platform into PathPresenter's global image-sharing platform, targeting laboratories, hospitals, and health systems worldwide. The collaboration aims to modernise the pathology industry by enhancing diagnostic accuracy, improving lab efficiencies, and ultimately benefiting patient outcomes. The integration of Ibex's clinically validated AI tools with PathPresenter's secure and scalable enterprise workflow platform is expected to provide a comprehensive solution for pathologists, connecting medical institutions globally.
PathPresenter, with its trusted position in over 45 tier-one institutions, serves as a crucial link for pathologists, fostering collaboration and knowledge-sharing on a global scale. The company, founded by dermatopathologist Dr. Rajendra Singh, envisions democratising access to pathology knowledge by facilitating the exchange of digital pathology images and AI models. Ibex's Galen™ platform, widely deployed in pathology, will play a pivotal role in this partnership, supporting clinicians worldwide during the diagnosis of various biopsies, including those for breast, prostate, and gastric cancers.
The collaboration underscores a commitment to advancing digital pathology adoption, leveraging AI tools, and building connections within the global pathology community. The joint initiative will be showcased at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in Baltimore.
Click here to read the original news story.